Latest Headlines

Latest Headlines

On a recall, 3-D printed knee implant maker ConforMIS falls 25% to IPO price

ConforMIS had one of the most staggeringly successful med tech IPOs this summer. Its July IPO raised more than $155 million at a $15 share price. The custom 3-D printed orthopedic implant company saw its share price climb as high as almost $27--but all that ground has been lost on this week's news of a voluntary recall by the company.

The massive med tech IPO: ConforMIS, Glaukos and Natera aim for $100M+

Custom knee implant maker ConforMIS has priced the latest major med tech IPO with its $135 million offering on July 1. Investor appetite for large med tech IPOs raising more than $100 million remains whetted, despite the encroachment of the summer doldrums that can slow Wall Street activity to a crawl.

Med techs gather IPO momentum: ConforMIS files for up to $173M, EndoChoice gets set as AirXpander starts in Australia

Med techs are looking to revive public market interest. Several IPOs priced during the first few months of the year--but there's been a lull lately. Custom joint replacement maker ConforMIS is readying an IPO to raise up to $172.5 million, while gastrointestinal endoscopy player EndoChoice has set terms to raise $100 million. Also, Palo Alto, CA-based, breast tissue expansion company AirXpander is starting an IPO to raise A$36.5 million (US $28.3 million) on the Australian Securities Exchange.

ConforMIS plots new moves after pumping up venture round to $168M

Orthopedic implant maker ConforMIS disclosed that it has expanded--and come close to doubling--its Series E financing to a whopping $167.7 million.

Top 10 VC Device deals of H1 2012

  These are dubious times for medical device companies seeking venture investment.  

Orthopedic implant maker ConforMIS blessed with $73M in new funding

ConforMIS successfully raised $73 million through the sale of stock and convertible securities on Wednesday. The fundraising, noted in a new regulatory filing, is a bit of a coup, in fact, surpassing an initially-announced plan to pull in $68 million through the action.

ConforMIS, an orthopedics implant maker, to raise $68M

ConforMIS, which makes orthopedics implants, plans to raise $68 million in an equity and securities funding round, according to a recent regulatory filing.

ConforMis nails $89M for iTotal knee manufacturing + launch

ConforMIS will use $89 million in newly raised investor financing to fuel the commercial launch and manufacturing of its new iTotal total knee replacement system. The Burlington, MA-based company

ConforMIS secures $1.4M loan from tech fund

ConforMIS has secured a $1.4 million loan from MassDevelopment's Emerging Technology Fund. The loan will go toward growing the Burlington, MA-based company's supply chain and manufacturing capacity

ConforMIS announces first procedures using iTotal CR knee system

ConforMIS said today that the first surgeries involving the iTotal CR knee resurfacing system were successfully completed in hospitals around the U.S. And, according to a company release, the